Amarillo Biosciences Inc is a biotechnology firm operating in global partnership with the Hayashibara Group, which also holds 32% of ABI' s shares.The
No takes yet. Share an insight, caveat, or question.
Cummins et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: